Stage IIIB Breast Cancer Completed Phase 1 Trials for Trastuzumab (DB00072)

IndicationStatusPhase
DBCOND0028549 (Stage IIIB Breast Cancer)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02060253Ganetespib, Paclitaxel, Trastuzumab and Pertuzumab for Metastatic Human Epidermal Growth Factor Receptor 2 Positive Breast CancerTreatment
NCT00004074Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/NeuTreatment